List of Tables
Table 1. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (US$ Million): (2017 VS 2021 VS 2028)
Table 2. Major Players of Anti-inflammatory Biologics
Table 3. Major Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Others
Table 6. Global Anti-inflammatory Therapeutics Market Size Growth by Application (2017 VS 2021 VS 2028)
Table 7. Global Anti-inflammatory Therapeutics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Anti-inflammatory Therapeutics Revenue (US$ Million) Market Share by Region (2017-2022))
Table 9. Global Anti-inflammatory Therapeutics Revenue Share by Region (2017-2022)
Table 10. Global Anti-inflammatory Therapeutics Revenue (US$ Million) Forecast by Region (2023-2028)
Table 11. Global Anti-inflammatory Therapeutics Revenue Share Forecast by Region (2023-2028)
Table 12. Global Anti-inflammatory Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 13. Global Anti-inflammatory Therapeutics Revenue Share by Players (2017-2022)
Table 14. Global Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Therapeutics as of 2021)
Table 15. Ranking of Global Top Anti-inflammatory Therapeutics Companies by Revenue (US$ Million) in 2021
Table 16. Global 5 Largest Players Market Share by Anti-inflammatory Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 17. Key Players Headquarters and Area Served
Table 18. Key Players Anti-inflammatory Therapeutics Product Solution and Service
Table 19. Date of Enter into Anti-inflammatory Therapeutics Market
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 22. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2017-2022)
Table 23. Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 24. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2023-2028)
Table 25. Global Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 26. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2017-2022)
Table 27. Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 28. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2023-2028)
Table 29. United States Anti-inflammatory Therapeutics Revenue by Company (2017-2022) & (US$ Million)
Table 30. United States Anti-inflammatory Therapeutics Revenue Market Share by Company (2017-2022)
Table 31. United States Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & ()
Table 32. United States Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & ()
Table 33. United States Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & ()
Table 34. United States Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & ()
Table 35. Europe Anti-inflammatory Therapeutics Revenue by Company (2017-2022) & (US$ Million)
Table 36. Europe Anti-inflammatory Therapeutics Revenue Market Share by Company (2017-2022)
Table 37. Europe Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 41. China Anti-inflammatory Therapeutics Revenue by Company (2017-2022) & (US$ Million)
Table 42. China Anti-inflammatory Therapeutics Revenue Market Share by Company (2017-2022)
Table 43. China Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 44. China Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 45. China Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 46. China Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 47. Japan Anti-inflammatory Therapeutics Revenue by Company (2017-2022) & (US$ Million)
Table 48. Japan Anti-inflammatory Therapeutics Revenue Market Share by Company (2017-2022)
Table 49. Japan Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 50. Japan Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 51. Japan Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 52. Japan Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 53. Southeast Asia Anti-inflammatory Therapeutics Revenue by Company (2017-2022) & (US$ Million)
Table 54. Southeast Asia Anti-inflammatory Therapeutics Revenue Market Share by Company (2017-2022)
Table 55. Southeast Asia Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 56. Southeast Asia Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 57. Southeast Asia Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 58. Southeast Asia Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 59. India Anti-inflammatory Therapeutics Revenue by Company (2017-2022) & (US$ Million)
Table 60. India Anti-inflammatory Therapeutics Revenue Market Share by Company (2017-2022)
Table 61. India Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 62. India Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 63. India Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 64. India Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 65. AbbVie Company Details
Table 66. AbbVie Description and Business Overview
Table 67. AbbVie Anti-inflammatory Therapeutics Product
Table 68. AbbVie Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 69. AbbVie Recent Development
Table 70. Johnson & Johnson Company Details
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Anti-inflammatory Therapeutics Product
Table 73. Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 74. Johnson & Johnson Recent Development
Table 75. Amgen Inc Company Details
Table 76. Amgen Inc Description and Business Overview
Table 77. Amgen Inc Anti-inflammatory Therapeutics Product
Table 78. Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Amgen Inc Recent Development
Table 80. AstraZeneca PLC Company Details
Table 81. AstraZeneca PLC Description and Business Overview
Table 82. AstraZeneca PLC Anti-inflammatory Therapeutics Product
Table 83. AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 84. AstraZeneca PLC Recent Development
Table 85. Pfizer, Inc Company Details
Table 86. Pfizer, Inc Description and Business Overview
Table 87. Pfizer, Inc Anti-inflammatory Therapeutics Product
Table 88. Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 89. Pfizer, Inc Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Description and Business Overview
Table 92. Novartis Anti-inflammatory Therapeutics Product
Table 93. Novartis Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 94. Novartis Recent Development
Table 95. Roche Company Details
Table 96. Roche Description and Business Overview
Table 97. Roche Anti-inflammatory Therapeutics Product
Table 98. Roche Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 99. Roche Recent Development
Table 100. Merck Company Details
Table 101. Merck Anti-inflammatory Therapeutics Product
Table 102. Merck Description and Business Overview
Table 103. Merck Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 104. Merck Recent Development
Table 105. Sanofi Company Details
Table 106. Sanofi Anti-inflammatory Therapeutics Product
Table 107. Sanofi Description and Business Overview
Table 108. Sanofi Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 109. Sanofi Recent Development
Table 110. GlaxoSmithKline Company Details
Table 111. GlaxoSmithKline Description and Business Overview
Table 112. GlaxoSmithKline Anti-inflammatory Therapeutics Product
Table 113. GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 114. GlaxoSmithKline Recent Development
Table 115. Sun Pharmaceutical Industries Ltd Company Details
Table 116. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 117. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product
Table 118. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 119. Sun Pharmaceutical Industries Ltd Recent Development
Table 120. TEVA Company Details
Table 121. TEVA Description and Business Overview
Table 122. TEVA Anti-inflammatory Therapeutics Product
Table 123. TEVA Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 124. TEVA Recent Development
Table 125. Anti-inflammatory Therapeutics Market Trends
Table 126. Anti-inflammatory Therapeutics Market Drivers
Table 127. Anti-inflammatory Therapeutics Market Challenges
Table 128. Anti-inflammatory Therapeutics Market Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-inflammatory Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Anti-inflammatory Biologics Features
Figure 3. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Features
Figure 4. Corticosteroids Features
Figure 5. Others Features
Figure 6. Global Anti-inflammatory Therapeutics Market Share by Application: 2021 VS 2028
Figure 7. Arthritis Case Studies
Figure 8. Respiratory Diseases Case Studies
Figure 9. Dermatology Case Studies
Figure 10. Gastroenterology Case Studies
Figure 11. Others Case Studies
Figure 12. Anti-inflammatory Therapeutics Report Years Considered
Figure 13. Global Anti-inflammatory Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Anti-inflammatory Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Anti-inflammatory Therapeutics Revenue Market Share by Region: 2017 VS 2021
Figure 16. United States Anti-inflammatory Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
Figure 17. Europe Anti-inflammatory Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
Figure 18. China Anti-inflammatory Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
Figure 19. Japan Anti-inflammatory Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
Figure 20. Southeast Asia Anti-inflammatory Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
Figure 21. India Anti-inflammatory Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
Figure 22. Global Anti-inflammatory Therapeutics Market Share by Players in 2021
Figure 23. Global Top Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapeutics as of 2021)
Figure 24. The Top 10 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2021
Figure 25. United States Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
Figure 26. United States Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
Figure 27. Europe Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
Figure 28. Europe Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
Figure 29. China Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
Figure 30. China Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
Figure 31. Japan Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
Figure 32. Japan Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
Figure 33. Southeast Asia Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
Figure 34. Southeast Asia Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
Figure 35. India Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
Figure 36. India Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
Figure 37. AbbVie Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
Figure 38. Johnson & Johnson Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
Figure 39. Amgen Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
Figure 40. AstraZeneca PLC Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
Figure 41. Pfizer, Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
Figure 42. Novartis Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
Figure 43. Roche Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
Figure 44. Merck Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
Figure 45. Sanofi Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
Figure 46. GlaxoSmithKline Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
Figure 47. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
Figure 48. TEVA Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed